Consensus recommendations on management of selumetinib-associated adverse events in pediatric patients with neurofibromatosis type 1 and plexiform neurofibromas / Azizi, Aa; Hargrave, D; Passos, J; Wolkenstein, P; Rosenbaum, T; Santoro, C; Rosenmayr, V; Pletschko, T; Ascierto, Pa; Hernández, Hs. - In: NEURO ONCOLOGY PRACTICE. - ISSN 2054-2585. - (2024). [10.1093/nop/npae038]
Consensus recommendations on management of selumetinib-associated adverse events in pediatric patients with neurofibromatosis type 1 and plexiform neurofibromas
Ascierto PA;
2024
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
